Merrimack Pharmaceuticals Inc

NASDAQ:MACK   3:56:13 PM EDT
4.31
+0.09 (+2.13%)
Earnings Announcements

Merrimack Reports Q2 Loss Per Share Of $0.04

Published: 08/04/2022 22:03 GMT
Merrimack Pharmaceuticals Inc (MACK) - Merrimack Reports Second Quarter 2022 Financial Results.
Q2 Loss per Share $0.04.
Merrimack Pharmaceuticals - As of June 30, 2022, Merrimack Had Cash and Cash Equivalents of $13.4 Million, Compared to $14.2 Million As of December 31, 2021.